Bragar Eagel & Squire, P.C., a nationally recognized stockholder rights law firm, is investigating potential claims against Clariant AG (“Clariant” or the “Company”) (Other OTC: CLZNY) on behalf of Clariant stockholders. Our investigation concerns whether Clariant has violated the federal securities laws and/or engaged in other unlawful business practices.

Click here to participate in the action.

On February 14, 2022, Swiss chemical maker, Clariant AG, disclosed that it will delay issuing Q4 2021 and full year 2021 financial results due an ongoing internal investigation into potential accounting fraud.

Clariant AG is investigating internal whistleblower complaints that the company has known about since September 2021, pertaining to booking issues aimed at boosting results to meet targets.

On this news, shares of Clariant AG ADR shares fell more than 14% in intraday trading on February 14, 2022.

If you purchased or otherwise acquired Clariant shares and suffered a loss, are a long-term stockholder, have information, would like to learn more about these claims, or have any questions concerning this announcement or your rights or interests with respect to these matters, please contact Brandon Walker or Alexandra Raymond by email at investigations@bespc.com, telephone at (212) 355-4648, or by filling out this contact form. There is no cost or obligation to you.

View source version on businesswire.com: https://www.businesswire.com/news/home/20220217005306/en/